Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Word is Getting Out!
View:
Post by Azzak34 on May 14, 2024 5:45am

Word is Getting Out!

https://news.sky.com/story/doctor-still-cancer-free-almost-a-year-after-incurable-brain-tumour-diagnosis-thanks-to-his-own-pioneering-treatment-13135621

Prof Long added: "We've shown that... you can activate the immune system and do it very well and this is now a foundational first step to change the field and the way drugs are explored in brain cancer."
Comment by Snowdrift on May 14, 2024 7:51am
Wow, this is really amazing!  He had STAGE 4 cancer! Thanks so much for sharing this, Azzak.
Comment by ENEMENEMYNEMO on May 14, 2024 8:45am
What you got Grade 8 Science Azz Whole?  This and Pela are not comparable in any way !!!
Comment by Azzak34 on May 14, 2024 8:54am
Hahaha immunotherapy isn't in any way comparable to immunotherapy and using the immune system to attack cancerous cells vs using the immune system to attack cancerous cells. It's a good point you make! 
Comment by ENEMENEMYNEMO on May 14, 2024 9:08am
What's your next deduction Dimmy...Pharmacotherapy is Pharmacotherapy??? Hmmm so I can take Amoxicillin for my high blood pressure. 
Comment by Azzak34 on May 14, 2024 9:19am
Haha what a dope. You made a fool of yourself and are doubling down?  For your high blood pressure I would suggest espressos and a bungee jump. Disclaimer *This is not intended to be medical advice* 
Comment by ENEMENEMYNEMO on May 14, 2024 9:29am
That's the best you got?   Thought you'd come back with something about STD's.... or does that cut too close Azzclap?
Comment by Azzak34 on May 14, 2024 9:31am
I think your main issue lies with a total misunderstanding of anything medical. Why would I talk about STDs as a causal effect on high blood pressure? Unless you want to admit something to the whole class?! 
Comment by ENEMENEMYNEMO on May 14, 2024 9:33am
Where am I ???
Comment by Azzak34 on May 14, 2024 9:45am
Ah Nemo is having an existential crisis and we are here to see it. 
Comment by Noteable on May 14, 2024 9:49am
" Nemo, Switzerland's non-binary artist, clinches the ESC's top prize with "The Code," a powerful track of self-discovery" https://www.dw.com/en/swiss-non-binary-singer-wins-2024-eurovision-song-contest/video-69056326
Comment by Buckhenry on May 14, 2024 10:35am
Another typo by unnoteable.... he meant to say he is getting out...
Comment by Noteable on May 14, 2024 10:56am
JP Morgan's Head of Big Data & AI Strategy Peng Cheng is out, after 14 years with JPM. 
Comment by Noteable on May 14, 2024 9:19am
"Prof Scolyer last year became the first brain cancer patient to ever have combination, pre-surgery immunotherapy.   He is also the first to be administered a vaccine personalised to his tumour's characteristics, which boosts the cancer-detecting powers of the drugs." https://www.bbc.com/news/world-australia-69006713 This is an pivotal example where a triplet I/O ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities